MLS Capital Fund II logo

MLS Capital Fund II

Asia, Kuala Lumpur, Malaysia, Kuala Lumpur

Description

MLS Capital Fund II invests in a diversified portfolio of biogreentech companies at all stages of development.

Investor Profile

MLS Capital Fund II has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series D, Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Agriculture, AgTech, Biotechnology.

Stage Focus

  • Series D (50%)
  • Post Ipo Equity (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Agriculture
  • Agtech
  • Biotechnology
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does MLS Capital Fund II frequently co-invest with?

Fall Line Capital
North America, California, United States, San Mateo
Co-Investments: 2
Baird Capital
North America, Wisconsin, United States, Milwaukee
Co-Investments: 1
CA
North America, Massachusetts, United States, Boston
Co-Investments: 2
Jeremy and Hannelore Grantham Environmental Trust
North America, Massachusetts, United States, Boston
Co-Investments: 2
AgFunder
North America, California, United States, San Francisco
Co-Investments: 1
Lupa Systems
North America, New York, United States, New York
Co-Investments: 1
S2G Ventures
North America, Illinois, United States, Chicago
Co-Investments: 2
Lewis & Clark Ventures
North America, Missouri, United States, St Louis
Co-Investments: 1
Spruce Capital Partners
North America, California, United States, San Francisco
Co-Investments: 2
Continental Grain Company
North America, New York, United States, New York
Co-Investments: 2

What are some of recent deals done by MLS Capital Fund II?

Greenlight Biosciences

Medford, Massachusetts, United States

GreenLight Biosciences is a biotechnology company that develops an RNA platform for agriculture and human health.

AgricultureAgTechBiotechnologyLife Science
Post Ipo EquityFeb 3, 2022
Amount Raised: $125,500,000
Greenlight Biosciences

Medford, Massachusetts, United States

GreenLight Biosciences is a biotechnology company that develops an RNA platform for agriculture and human health.

AgricultureAgTechBiotechnologyLife Science
Series DJun 16, 2020
Amount Raised: $102,000,000

Find More Investors Like MLS Capital Fund II

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

MLS Capital Fund II | Pipeseed